Search
for
Sort by
Research 241–270 of 526
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Scalp Microbiota Dysbiosis in Seborrheic Alopecia and Restoration Following Herbal Extract Shampoo Intervention
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Resident Memory T Cells in Autoimmune Skin Diseases
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance
- Alopecia Areata: An Updated Review for 2023
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Hair follicle immune privilege and its collapse in alopecia areata
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- The potential of regulatory T cell-based therapies for alopecia areata
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials